£340K
The seed round was backed by returning angel investors and the Women Angels of the North Syndicate.
"This is a really exciting investment for us. The money will allow us to build on the foundations we have put in place and grow our business by bringing in new team members with skillsets that will strengthen our existing operation. It has been fantastic to see investors from the pre-seed round re-investing for a second time. They are very supportive in seeing us achieve our mission to accelerate research and improve the outcomes for people with rare cancers."